COVID-19: Herd immunity and convalescent plasma transfer therapy
- 10 July 2020
- journal article
- editorial
- Published by Wiley in Journal of Medical Virology
- Vol. 92 (9), 1380-1382
- https://doi.org/10.1002/jmv.25870
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Targeting of keloid with TRAIL and TRAIL-R2/DR5Journal of Dermatological Treatment, 2021
- Difference Between Medical and Nonmedical Students on Knowledge, Practice, and Attitude Towards the Human Papillomavirus Vaccine in China: a Cross-Sectional StudyJournal of Cancer Education, 2021
- Convalescent plasma as a potential therapy for COVID-19The Lancet Infectious Diseases, 2020
- The reproductive number of COVID-19 is higher compared to SARS coronavirusJournal of Travel Medicine, 2020
- Understanding of COVID‐19 based on current evidenceJournal of Medical Virology, 2020
- Anti-Ebola Virus Antibody Levels in Convalescent Plasma and Viral Load After Plasma Infusion in Patients With Ebola Virus DiseaseThe Journal of Infectious Diseases, 2018
- Convalescent plasma: new evidence for an old therapeutic tool?2015
- Estimates of the reproduction number for seasonal, pandemic, and zoonotic influenza: a systematic review of the literatureBMC Infectious Diseases, 2014
- "Herd Immunity": A Rough GuideClinical Infectious Diseases, 2011
- Perspectives on the basic reproductive ratioJournal of The Royal Society Interface, 2005